Patient Education: An Efficient Adjuvant Therapy for Hyperphosphatemia in Hemodialysis Patients
Authors:
- Kuo-Chuan ChangKCKuo-Chuan Chang
- Sue-Hsien ChenSCSue-Hsien Chen
- Chiz-Tzung ChangCCChiz-Tzung Chang
- Mai-Szu WuMWMai-Szu Wu
- 1 January 2008
- journal article
- Published by Taylor & Francis in Renal Failure
- Vol. 30 (1) , 57-62
Abstract
Hemodialysis and phosphate (P) binder therapy are the major methods to reduce the phosphate level in dialysis patients. However, dietary P restriction is necessary for adequate control. The successful dietary control is based on patient compliance. Patient education is the best method to assure the knowledge and drive of dietary control, which are the key features for patient compliance. The aim of the study is to investigate quantitatively the effect of patient education on serum P levels in hyperphosphatemic hemodialysis patients. We conducted a prospective self-control study. Fifty hemodialysis patients with a pre-dialysis serum P level greater than 6.0 mg/dL were studied. Intensified patient education was given. Serum P, calcium (Ca), and intact parathyroid hormone (iPTH) were evaluated before and one month after patient education. Thirty-six (72%) patients had improved pre-dialysis P level (pre-education: 7.50 +/- 1.33; post-education: 5.85 +/- 1.20 mg/dL, p < 0.001) and Ca x P product (pre-education: 68.17 +/- 12.70; post-education: 54.70 +/- 11.87 mg(2)/dL(2), p < 0.001). The effect lasted for at least three months. There is no significant change on calcium levels. The only predictor of a successful patient education is the iPTH level (improved: 348.8 +/- 277.6; non-improved: 668.0 +/- 674.1 ng/mL, p = 0.021). Patient education could be helpful and efficient in hyperphosphatemic control in dialysis patients. The patient education should be given before the serum iPTH level getting high.Keywords
This publication has 14 references indexed in Scilit:
- Effects of the calcimimetic cinacalcet HCl on cardiovascular disease, fracture, and health-related quality of life in secondary hyperparathyroidismKidney International, 2005
- Mild Hyperphosphatemia and Mortality in Hemodialysis PatientsAmerican Journal of Kidney Diseases, 2005
- Treatment of hyperphosphatemia in patients with chronic kidney disease on maintenance hemodialysisKidney International, 2005
- Hyperphosphatemia in children receiving peritoneal dialysis—an educational programPediatric Nephrology, 2005
- Vascular calcification: A stiff challenge for the nephrologistKidney International, 2004
- Mineral Metabolism, Mortality, and Morbidity in Maintenance HemodialysisJournal of the American Society of Nephrology, 2004
- The role of sevelamer in achieving the kidney disease outcomes quality initiative (K/DOQI) guidelines for hyperphosphatemiaCurrent Medical Research and Opinion, 2004
- Control of serum phosphate in patients with renal failure - new approachesNephrology Dialysis Transplantation, 1998
- Methods of controlling hyperphosphatemia in patients with chronic renal failureCurrent Opinion in Nephrology and Hypertension, 1993
- Hyperphosphatemia: Its Consequences and Treatment in Patients With Chronic Renal DiseaseAmerican Journal of Kidney Diseases, 1992